The Most Compelling Evidence For The Presence Of Graphene Oxide Nanotechnology In the COVID-19 "Vaccines"
This Substack has recently reviewed the issue of Graphene Oxide in the slow kill bioweapon injections in conjunction with the modified Spike Proteins, or SP 2:
In an even deeper dive on the presence of Graphene Oxide in these “vaccines” we now have irrefutable proof that all of the BigPharma DEATHVAX™ manufacturers on behalf of their coconspirators the DoD, Pentagon, et al. included this cytotoxic ingredient. An ingredient, mind you, that has nothing to do with prevention, transmissibility or attenuation of PSYOP-19 symptoms, and in no way preserves, improves, or adds any benefit to the actual products.
In the summer of 2021 Dr. Campras and his team analyzed four different PSYOP-19 “vaccines:” Pfizer-BioNtech's Comirnaty, Astrazeneca's Vaxzevria, Johnson & Johnson's Janssen, and Moderna's.
These were their published findings:
In the case of the Pfizer-BioNtech vaccine (Comirnaty), an abundance of transparent 2D laminar objects were found, which, the company suggested, resemble Graphene Oxide. The images obtained from the vaccine sample were compared to images of graphene oxide from previous studies, and a standard reduced graphene oxide sample.
Using transmission electron microscopy, the laminar objects were further analyzed and similarities were found with graphene oxide imagery in scientific literature. The analysis had clearly demonstrated the presence of an intricate matrix or mesh of folded translucent flexible sheets with darker multilayer agglomerations and lighter unfolded monolayers.
A quantification of mRNA in the Comirnaty sample was also performed, showing that most of the absorbance in the sample might be due to these graphene-like sheets, suggesting a high concentration of this material.
The fluorescence measurements also aligned with the peak values for reduced graphene oxide.
This is probably the most convincing evidence in existence that the Graphene Oxide nanotechnology is a deliberate component of these injections, and the implications are horrifying.
The published findings of Dr. Campras’ analysees of Graphene Oxide in the vaccines:
We have carried out a random screening of graphene-like nanoparticles visible at the optical microscopy in seven random samples of vials from four different trademarks, coupling images with their spectral signatures of RAMAN vibration. By this technique, called micro-RAMAN, we have been able to determine the presence of graphene in some of these samples, after screening more than 110 objects selected for their graphene-like appearance under optical microscopy. Out of them, a group of 28 objects have been selected, due to the compatibility of both images and spectra with the presence of graphene derivatives, based on the correspondence of these signals with those obtained from standards and scientific literature. The identification of graphene oxide structures can be regarded as conclusive in 8 of them, due to the high spectral correlation with the standard. In the remaining 20 objects, images coupled with Raman signals show a very high level of compatibility with undetermined graphene structures, however different than the standard used here. This research remains open and is made available to scientific community for discussion. We make a call for independent researchers, with no conflict of interest or coaction from any institution to make wider counter-analysis of these products to achieve a more detailed knowledge of the composition and potential health risk of these experimental drugs, reminding that graphene materials have a potential toxicity on human beings and its presence has not been declared in any emergency use authorization.
Microscopic study of the sample provides strong evidence for the probable presence of graphene derivatives, although microscopy does not provide conclusive evidence. The definitive identification of graphene, oxidized graphene (GO) or reduced oxidized graphene (rGO) in the RD1 sample requires the STRUCTURAL CHARACTERIZATION through the analysis of specific spectral standard sample comparable to those published in literature and those obtained from the standard sample, obtained with spectroscopic techniques such as XPS, EDS, NMR, FTIR or Raman, among others.
Dr. Campras’ findings are presenting the most compelling data of the existence of Graphene Oxide in these injections.
It is important to appreciate that NO OFFICIAL COUNTER-ANALYSIS FROM REGULATORY AGENCIES has been done or published.
The process of emergency authorization (EUA) has meant that control and verification of the final product before its distribution WAS ONLY BASED ON DOCUMENTS PROVIDED BY MANUFACTURERS.
So why exactly was Graphene Oxide added to these depopulation injections?
Do NOT comply.